
Quotient Limited QTNT
Quartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Quotient Limited Allgemeine Reserven 2011-2026 | QTNT
Allgemeine Reserven Jährlich Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 22 M | 20.5 M | 15.6 M | 16.3 M | 13.6 M | 12.6 M | 4.61 M | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 22 M | 4.61 M | 15 M |
Allgemeine Reserven Vierteljährlich Quotient Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.3 M | 12.8 M | 22.1 M | 22 M | 22.8 M | 25 M | 23.2 M | 23.2 M | 23.7 M | 23.7 M | 22.8 M | 21.3 M | 19.8 M | 18.1 M | 16.7 M | 15.6 M | 15.3 M | 15.3 M | 15.6 M | 16.3 M | 16.5 M | 15.2 M | 14.8 M | 13.6 M | 13.2 M | 13.4 M | 12.8 M | 12.6 M | 7.81 M | 5.83 M | 5.01 M | 4.61 M | 4.59 M | 4.42 M | 4.64 M | 4.56 M | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 25 M | 4.42 M | 15.1 M |
Allgemeine Reserven anderer Aktien in der Diagnostik & Forschung
| Name | Allgemeine Reserven | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M | ||
|
Agilent Technologies
A
|
830 M | $ 118.37 | -1.17 % | $ 36 B | ||
|
Burning Rock Biotech Limited
BNR
|
123 M | $ 20.14 | -2.04 % | $ 217 M | ||
|
Aspira Women's Health
AWH
|
256 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
26.7 M | $ 22.07 | 25.61 % | $ 1.18 B | ||
|
NeoGenomics
NEO
|
28.6 M | $ 8.14 | -6.22 % | $ 1.04 B | ||
|
Neogen Corporation
NEOG
|
191 M | $ 9.26 | -1.7 % | $ 2.01 B | ||
|
Exact Sciences Corporation
EXAS
|
166 M | - | - | $ 19.8 B | ||
|
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
992 K | $ 1.42 | - | $ 1.89 M | ||
|
Castle Biosciences
CSTL
|
8.14 M | $ 24.4 | -0.89 % | $ 678 M | ||
|
Senseonics Holdings
SENS
|
6.7 M | $ 6.78 | -1.81 % | $ 283 M | ||
|
Soleno Therapeutics
SLNO
|
15 M | $ 52.59 | 0.03 % | $ 2.67 B | ||
|
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M | ||
|
Neuronetics
STIM
|
4.33 M | $ 1.41 | 1.08 % | $ 93 M | ||
|
Charles River Laboratories International
CRL
|
299 M | $ 180.6 | 0.02 % | $ 8.95 B | ||
|
Thermo Fisher Scientific
TMO
|
5.42 B | $ 520.64 | -2.04 % | $ 196 B | ||
|
Danaher Corporation
DHR
|
2.49 B | $ 194.14 | -2.02 % | $ 138 B | ||
|
Interpace Biosciences
IDXG
|
1.11 M | $ 2.2 | - | $ 9.73 M | ||
|
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | ||
|
Twist Bioscience Corporation
TWST
|
28.3 M | $ 56.1 | -2.65 % | $ 3.36 B | ||
|
Illumina
ILMN
|
547 M | $ 131.42 | -0.64 % | $ 20.9 B | ||
|
Guardant Health
GH
|
85.9 M | $ 84.82 | -0.05 % | $ 10.6 B | ||
|
QIAGEN N.V.
QGEN
|
302 M | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
1.49 M | $ 2.21 | 4.5 % | $ 5.08 M | ||
|
ICON Public Limited Company
ICLR
|
2.3 M | $ 117.7 | 1.03 % | $ 9.71 B | ||
|
Waters Corporation
WAT
|
572 M | $ 323.16 | -0.93 % | $ 19.2 B | ||
|
Laboratory Corporation of America Holdings
LH
|
535 M | $ 267.93 | 0.45 % | $ 22.3 B | ||
|
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K | ||
|
Myriad Genetics
MYGN
|
30.6 M | $ 5.13 | -1.25 % | $ 475 M | ||
|
Lantheus Holdings
LNTH
|
64.7 M | $ 83.18 | -0.91 % | $ 5.61 B | ||
|
Quest Diagnostics Incorporated
DGX
|
189 M | $ 193.13 | 0.89 % | $ 21.4 B |